Amid India-China geopolitical tensions, China’s Fosun Pharmaceutical is in discussions with three global private equity firms to sell its majority stake in the Hyderabad-based Gland Pharma.Read More
Three global PE firms vie to buy Hyderabad’s Gland Pharma from its Chinese owner
Related Posts
Add A Comment